The inhibition of cell apoptosis by the upregulated antiapoptotic protein Bcl-2 confers a survival advantage, and its inhibition has been known to be involved in chemotherapeutic resistance in various types of cancers [41,42]. The gene discussed is BCL2; the disease is cancer.